| Catalog No. | HW741016 |
|---|
| Species reactivity | Human |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Host species | Humanized |
|---|
| Isotype | IgG2-G4-kappa |
|---|
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
OX-2 membrane glycoprotein, MOX2, MOX1, CD200 |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Accession |
P41217 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
|
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | ALXN6000, Anti-CD200, hB7V3V2G2G4, 1073059-33-2 |
|---|
| Background | Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research.
• Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors., PMID:11423130
• Mox2 is a component of the genetic hierarchy controlling limb muscle development., PMID:10403250
|
|---|
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
中文
English
